Paradigm Strategies in Wealth Management’s State Street SPDR Portfolio Emerging Markets ETF SPEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-8,143
Closed -$381K – 54
2025
Q3
$381K Hold
8,143
– – 0.24% 39
2025
Q2
$348K Hold
8,143
– – 0.23% 40
2025
Q1
$321K Sell
8,143
-26
-0.3% -$1.02K 0.22% 38
2024
Q4
$313K Buy
8,169
+519
+7% +$20.9K 0.21% 38
2024
Q3
$316K Sell
7,650
-385
-5% -$14.8K 0.2% 36
2024
Q2
$303K Sell
8,035
-4,165
-34% -$155K 0.19% 37
2024
Q1
$442K Sell
12,200
-2,687
-18% -$94.5K 0.27% 30
2023
Q4
$527K Sell
14,887
-8,596
-37% -$292K 0.35% 25
2023
Q3
$788K Sell
23,483
-10,825
-32% -$374K 0.5% 21
2023
Q2
$1.18M Buy
+34,308
New +$1.17M 0.8% 18

Other funds holding SPEM

Paradigm Strategies in Wealth Management's SPEM Position: Q4 2025 in Review

Paradigm Strategies in Wealth Management sold out of State Street SPDR Portfolio Emerging Markets ETF (SPEM) in Q4 2025, closing a stake of 8,143 shares — an estimated $381K sold.

Paradigm Strategies in Wealth Management first reported a position in SPEM in Q2 2023 and held it in 10 quarters. The position peaked at $1.18M in Q2 2023. 984 funds tracked by Wall St. Rank hold SPEM as of Q4 2025.

  • Paradigm Strategies in Wealth Management reported no remaining State Street SPDR Portfolio Emerging Markets ETF position as of Q4 2025 after selling out during the quarter.
  • Paradigm Strategies in Wealth Management sold 8,143 State Street SPDR Portfolio Emerging Markets ETF shares in Q4 2025, an estimated $381K.
  • Paradigm Strategies in Wealth Management first reported a position in State Street SPDR Portfolio Emerging Markets ETF in Q2 2023 and held it in 10 quarters.
  • Paradigm Strategies in Wealth Management's State Street SPDR Portfolio Emerging Markets ETF position peaked at $1.18M in Q2 2023.
  • 984 funds tracked by Wall St. Rank held State Street SPDR Portfolio Emerging Markets ETF as of Q4 2025.

Based on Paradigm Strategies in Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.